middl
east
respiratori
syndrom
coronaviru
merscov
one
fear
diseas
mortal
possibl
global
outbreak
januari
laboratoryconfirm
case
merscov
includ
associ
death
casefat
rate
report
global
korea
may
confirm
case
includ
associ
death
report
outbreak
caus
one
infect
person
saudi
arabia
present
effect
vaccin
therapeut
avail
prevent
treatment
merscov
infect
howev
variou
basic
clinic
research
ongo
screen
varieti
natur
product
merscov
attempt
develop
antimerscov
drug
mani
flavonoid
show
antim
activ
among
deriv
eg
bavachin
bavachnin
separ
dri
seed
psoralea
corylifolia
l
korean
medicin
herb
exhibit
compar
good
activ
bavachin
deriv
report
divers
biolog
activ
includ
anticanc
ppar
agonist
antiinflammatori
antialzheim
immunomodulatori
antiosteoporosi
antivir
carp
viru
influenza
activ
synthesi
racem
mixtur
bavachin
deriv
report
compound
proven
ppar
agonist
anticanc
reagent
howev
exchang
phenol
group
anilin
group
tri
bavachin
bavachinin
show
good
antimerscov
activ
respect
phenotyp
cellular
screen
vero
cell
small
structur
differ
two
compound
oh
vs
ome
could
chang
antivir
activ
tri
synthes
bavachin
deriv
structureactivityrelationship
studi
sar
studi
first
synthes
racem
bavachinin
accord
procedur
report
du
et
al
doubl
bond
side
chain
reduc
hydrogen
pdc
prepar
oxid
chroman
ring
perform
produc
scheme
synthes
modifi
procedur
react
nbocprotect
aldol
condens
give
cycliz
kf
produc
scheme
derivat
perform
substitut
phenol
oh
nh
group
exampl
racem
bavachnin
react
iodomethan
benzyl
bromid
presenc
potassium
carbon
afford
respect
derivat
phenol
group
perform
similar
procedur
shown
scheme
prepar
prepar
acetyl
propargyl
amino
group
shown
scheme
total
compound
bavachinin
deriv
four
core
structur
evalu
figur
antimerscov
activ
cellcytotox
cellular
phenotyp
screen
method
shown
tabl
activ
synthes
racem
bavachin
around
half
natur
bavachin
omethyl
racem
bavachnin
show
similar
activ
natur
bavachinin
entri
tabl
alkyl
phenol
oh
isopropyl
benzyl
group
decreas
antim
activ
entri
tabl
prepar
hydrogen
extern
doubl
bond
show
best
antim
activ
regardless
osubstitu
interestingli
oisopropyl
note
obenzyl
deriv
respect
show
similar
activ
nonsubstitut
better
omethyl
cytotox
vero
cell
also
increas
show
good
activ
similar
howev
cytotox
much
less
consid
activ
cytotox
thought
best
compound
antim
drug
pharmacokinet
studi
perform
rat
iv
po
could
detect
plasma
min
iv
po
studi
rapid
clearanc
liver
microsom
phase
stabil
remain
min
rat
decid
chang
phenol
oh
group
amino
group
base
assumpt
phenol
oh
group
concern
instabl
plasma
though
bioavail
satisfactori
liver
microsom
phase
stabil
improv
result
pharmacokinet
studi
afford
accept
curv
iv
po
studi
shown
figur
antim
activ
littl
decreas
compar
howev
antim
activ
deriv
conserv
also
exhibit
antivir
activ
sarscov
vero
cell
conclus
seri
deriv
synthes
chemic
modif
bavachin
exhibit
antim
activ
vero
cell
show
best
activ
thought
best
compound
antim
drug
consider
cytotox
modif
phenol
group
amino
group
could
much
improv
pharmacokinet
properti
expect
studi
bavachin
deriv
contribut
develop
antim
drug
scheme
oalkyl
reagent
condit
iodomethan
k
co
dmf
rt
overnight
k
co
dmf
c
overnight
benzyl
bromid
k
co
dmf
rt
overnight
immunofluoresc
stain
fix
cell
permeabil
triton
sigmaaldrich
st
loui
mo
usa
min
cell
incub
rabbit
antimerscov
spike
antibodi
h
c
three
wash
pb
cell
incub
alexa
goat
antirabbit
igg
h
l
secondari
antibodi
hoechst
life
technolog
waltham
usa
h
c
imag
acquir
perkin
elmer
operetta
waltham
usa
acquir
imag
analyz
inhousedevelop
imagemin
im
plugin
softwar
previous
describ
pmid
analyz
imag
total
number
cell
number
infect
cell
determin
count
hoechststain
nuclei
spike
proteinexpress
cell
respect
infect
ratio
well
normal
use
averag
infect
ratio
mock
control
averag
infect
ratio
neg
control
dmso
assay
plate
cell
ratio
determin
accord
number
cell
well
versu
averag
number
cell
mock
control
assay
plate
work
merscov
perform
enhanc
biosafeti
facil
institut
pasteur
korea
